about
Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study.Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.Heart protection: a key target in the management of patients with diabetes.Arterial Stiffness Impairment in Sickle Cell Disease Associated With Chronic Vascular Complications: The Multinational African CADRE Study.Refractory hypoglycemia controlled by sorafenib in solitary fibrous tumor.[Idiopathic retroperitoneal fibrosis: a multicentric retrospective study of 30 French cases and follow-up of the renal function].Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles[Risk of venous thromboembolism in acute medical illnesses. Part 2: Situations at risk in ambulatory, hospital and internal medicine settings][Risk of venous thromboembolism in the course of acute medical illness. Part 1: Basic research, clinical models, descriptive and analytic epidemiology]Aortic pulse pressure and atherosclerotic structural alterations of coronary arteries[Vitamine K antagonists overdose: Physician adherence to the French guidelines][Correlation between urinary catecholamines dosage and apnea-hypopnea index in a hypertension population: pilot study][Usefulness of different techniques of blood pressure measurements in 2016]
P50
Q33443268-88D99F13-244F-4D65-A7F6-3DD01E803EA2Q35813199-57E8B419-912E-4CFF-AC6D-EBCD09A219ACQ37778401-C0D91C6B-10AA-4C15-B875-57F3D67446FFQ45189450-94B6FF16-66D2-48D2-92DD-A8ED50F18523Q53752545-7EE0FB28-2C9F-48C1-93AE-37C790911F7DQ54454939-4F59AB72-7352-487E-81FB-529B4EA9D6CDQ54477311-7A943DEF-873F-4CF4-98DB-37113418FAB4Q59617540-FD6D4282-BE0F-4F78-8D6D-CE6A0B566DF3Q81049992-14D664BF-6452-4D53-8B84-753A3295F4B9Q81056900-41DBD335-E04D-47B8-BDA5-23D4C95CFEFAQ83825671-3A6B33DF-69F9-46DE-A6CB-37479CB9C77CQ88087584-297EA7A2-BAEA-45B2-9E75-1067709D1534Q88127327-21E1AA90-9197-4B4A-AD80-923D3821635DQ88746863-2A107F65-7117-44CB-A580-FAD8129E3E77
P50
description
researcher ORCID ID = 0000-0002-2897-8102
@en
name
Sylvain Le Jeune
@ast
Sylvain Le Jeune
@en
Sylvain Le Jeune
@es
Sylvain Le Jeune
@nl
type
label
Sylvain Le Jeune
@ast
Sylvain Le Jeune
@en
Sylvain Le Jeune
@es
Sylvain Le Jeune
@nl
prefLabel
Sylvain Le Jeune
@ast
Sylvain Le Jeune
@en
Sylvain Le Jeune
@es
Sylvain Le Jeune
@nl
P1153
26433605900
P21
P31
P496
0000-0002-2897-8102